158 related articles for article (PubMed ID: 23558966)
21. Association between the XRCC3 Thr241Met polymorphism and risk of colorectal cancer: a meta analysis of 5,193 cases and 6,645 controls.
Namazi A; Abedinzadeh M; Nourbaksh P; Neamatzadeh H
Asian Pac J Cancer Prev; 2015; 16(6):2263-8. PubMed ID: 25824748
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive assessment of the association between DNA repair gene XRCC3 Thr241Met polymorphism and leukemia risk.
Qin L; Chen X; Li P; Yang Z; Mo W
Tumour Biol; 2014 Mar; 35(3):2521-8. PubMed ID: 24197983
[TBL] [Abstract][Full Text] [Related]
23. Haplotype-based case-control study of DNA repair gene XRCC3 and hepatocellular carcinoma risk in a Chinese population.
Luo HC; Zhang HB; Xin XJ; Huang WX
Tumour Biol; 2014 Apr; 35(4):3415-9. PubMed ID: 24307625
[TBL] [Abstract][Full Text] [Related]
24. XRCC3 T241M polymorphism and melanoma skin cancer risk: A meta-analysis.
Fan J; Fan Y; Kang X; Zhao L
Oncol Lett; 2015 May; 9(5):2425-2429. PubMed ID: 26137085
[TBL] [Abstract][Full Text] [Related]
25. Polymorphisms of excision repair gene XPD Lys751Gln and hOGG1 Ser326Cys might not be associated with hepatocellular carcinoma risk: a meta-analysis.
Zhang RC; Mou SH
Tumour Biol; 2013 Apr; 34(2):901-7. PubMed ID: 23271362
[TBL] [Abstract][Full Text] [Related]
26. Association between XRCC3 Thr241Met polymorphism and risk of osteosarcoma in a Chinese population.
Yang L; An Y; Wang G; Lu T; Yang S
Int J Clin Exp Pathol; 2015; 8(9):11670-4. PubMed ID: 26617908
[TBL] [Abstract][Full Text] [Related]
27. Meta-analysis of the relationship between XRCC3 T241M polymorphism and colorectal cancer susceptibility.
Zhang LZ; Li YS; Liu HZ
Genet Mol Res; 2015 Nov; 14(4):14831-9. PubMed ID: 26600544
[TBL] [Abstract][Full Text] [Related]
28. XRCC3 Thr241Met polymorphism and breast cancer risk: a meta-analysis.
Economopoulos KP; Sergentanis TN
Breast Cancer Res Treat; 2010 Jun; 121(2):439-43. PubMed ID: 19789975
[TBL] [Abstract][Full Text] [Related]
29. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis.
Liu F; Li B; Wei Y; Yan L; Wen T; Zhao J; Xu M
Liver Int; 2011 Jul; 31(6):802-9. PubMed ID: 21645210
[TBL] [Abstract][Full Text] [Related]
30. Association between the XRCC3 polymorphisms and breast cancer risk: meta-analysis based on case-control studies.
He XF; Wei W; Su J; Yang ZX; Liu Y; Zhang Y; Ding DP; Wang W
Mol Biol Rep; 2012 May; 39(5):5125-34. PubMed ID: 22161248
[TBL] [Abstract][Full Text] [Related]
31. The association of six non-synonymous variants in three DNA repair genes with hepatocellular carcinoma risk: a meta-analysis.
Shi YH; Wang B; Xu BP; Jiang DN; Zhao DM; Ji MR; Zhou L; Li X; Lu CZ
J Cell Mol Med; 2016 Nov; 20(11):2056-2063. PubMed ID: 27306318
[TBL] [Abstract][Full Text] [Related]
32. Association between the XRCC3 C241T polymorphism and lung cancer risk in the Asian population.
Tian X; Tian Y; Ma P; Sui C; Meng F; Li Y; Fu L; Jiang T; Wang Y; Jiang Y
Tumour Biol; 2013 Oct; 34(5):2589-97. PubMed ID: 23749486
[TBL] [Abstract][Full Text] [Related]
33. Quantitative assessment of the associations between DNA repair gene XRCC3 Thr241Met polymorphism and gastric cancer.
Wang Z; Chen X; Liu B; Li S; Liu M; Xue H
Tumour Biol; 2014 Feb; 35(2):1589-98. PubMed ID: 24197974
[TBL] [Abstract][Full Text] [Related]
34. Association between the Thr241Met polymorphism of X-ray repair cross-complementing group 3 gene and glioma risk: evidence from a meta-analysis based on 4,136 cases and 5,233 controls.
Lin J; Kou Y
Tumour Biol; 2014 Jan; 35(1):425-32. PubMed ID: 23918307
[TBL] [Abstract][Full Text] [Related]
35. Association between the XRCC3 Thr241Met Polymorphism and Gastrointestinal Cancer Risk: A Meta-Analysis.
Sahami-Fard MH; Mousa Mayali AR; Tajehmiri A
Asian Pac J Cancer Prev; 2016 Oct; 17(10):4599-4608. PubMed ID: 27892671
[TBL] [Abstract][Full Text] [Related]
36. Association of X-ray cross-complementing group 3 Thr241Met gene polymorphism with osteosarcoma risk and its development and prognosis.
Wang Y; Wang G; Dong Z
J Cancer Res Ther; 2018 Dec; 14(Supplement):S1178-S1182. PubMed ID: 30539867
[TBL] [Abstract][Full Text] [Related]
37. Genetic polymorphisms of XRCC3 Thr241Met (C18067T, rs861539) and bladder cancer risk: a meta-analysis of 18 research studies.
Ma Q; Zhao Y; Wang S; Zhang X; Zhang J; Du M; Li L; Zhang Y
Tumour Biol; 2014 Feb; 35(2):1473-80. PubMed ID: 24085356
[TBL] [Abstract][Full Text] [Related]
38. The association of XRCC3 Thr241Met genetic variant with risk of prostate cancer: a meta-analysis.
Xuan G; Hui Y; Fang H
Afr Health Sci; 2015 Mar; 15(1):117-22. PubMed ID: 25834539
[TBL] [Abstract][Full Text] [Related]
39. Ethnicity-stratified analysis of the association between XRCC3 Thr241Met polymorphism and leukemia: an updated meta-analysis.
Xie Z; Peng W; Li Q; Cheng W; Zhao X
BMC Med Genomics; 2021 Sep; 14(1):229. PubMed ID: 34537044
[TBL] [Abstract][Full Text] [Related]
40. Association between XRCC3 Thr241Met polymorphism and nasopharyngeal carcinoma risk: evidence from a large-scale case-control study and a meta-analysis.
Cui Q; Zuo XY; Lian YF; Feng QS; Xia YF; He CY; Chen LZ; Jia WH; Mai HQ; Zeng YX; Bei JX
Tumour Biol; 2016 Nov; 37(11):14825-14830. PubMed ID: 27639382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
